Previous studies have demonstrated alterations in polymorphonuclear leukocyte (PMNL) function in patients with psoriasis, but results have been variable. In this study we attempted to determine whether functional changes in PMNL from psoriatics represented an intrinsic cellular defect or a response to factors in serum. We evaluated the effect of the continuous presence of autologous and heterologous serum on lysozyme release and superoxide anion (0 2 -) generation by psoriatic and normal PMNL exposed to a soluble or particulate phagocytic stimulus. There were no differences in 02-generation or lysozyme release between normal and psoriatic PMNL without serum. However, in the presence of 10% autologous serum, these responses were significantly decreased for psoriatic PMNL (p < .001). The results were not time-dependent and did not correlate with the extent of psoriatic involvement. The data support the hypothesis that serum factors exist in patients with psoriasis that may affect PMNL functions. The presence or absence of such factors could explain, in part, the differences between the various investigations of PMNL function in psoriasis.
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Several studies have demonstrated alterations in granulocyte function in patients with psoriasis. These changes include enhancement of granulocyte adherence (1] , random migration (2] , chemotaxis [3] , phagocytosis [3] , antibody-dependent cellmediated cytotoxicity [4] , and hexose monophosphate shunt activity [ 5] . Since these alterations are not always correlated with activity or extent of disease, it is not clear that t hey are secondary to epidermal hyperprofileration. Moreover, it is not possib le to assign an etiologic role to such findings since while polymorphonuclear leukocytes (PMNL) may be present in dermal and epidermal inflammatory infiltrates of psoriatic lesions, mononuclear cells usually predominate, and clinical pustu lation is exceptionaL
In the present studies, we attempted to further characterize the functional changes in PMNL from psoriatics and to determine whether they represent an intrinsic cellular defect(s) or a response to soluble circulating factor(s) in serum. Thus we measured the effect of the continuous presence of autologous and heterologous serum on the responses of psoriatic and Manu scrip t rece ived August 15, 1983 ; accepted for publication November 14, 1983 .
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MATERIALS AND METHODS

Subjects
Patients see n at the Ohio State University Hospital Dermatology Clinic with psoriasis diagnosed by establi shed clinical and histopathologic criteria were as ked to participate. Healthy laboratory perso nnel with no personal or immediate family history of psoriasis se rved as paired controls. Informed consent was obtained from all subjects. No subject was receiving systemic medications, but some psoriatics were usin g topica l medications (corticosteroids, coal tar products, anthralin).
Preparation. of Cell. Suspensions and Serum
Fifty milliliters of heparinized (10 U/mll venous blood was obtained from subjects by venipuncture. Purified preparations of PMNL were isolated by means of Hypaque-Ficoll gradients followed by dextran sedimentation and hypotonic lysis of erythrocytes. This method yie lded 100-200 X 10" PMNL depending upon the peripheral leukocyte count. Viability determined by trypan blue excl usion was 98 ± 2%. The cells were suspe nded in a buffered salt solut ion consisting of 138 mM NaCJ, 2.7 mM KCI, 8.1 mM Na 2 HPO . ., 1.5 mM KHzPO . ., 1.0 mM MgCI 2 , and 0.6 mM CaCI 2 , pH 7.4 (hereafter referred to as PiCM) .
Whole blood was withdrawn simultaneously and allowed to clot at room temperature for 30 min. Serum was separated by centrifugation at 3000 rpm for 15 min and used the same day.
PMNL from psoriatic donors were always studied with a paired norm al control donor. Autologous serum refers to the donor's serum on the day of t he ex periment.
Preparation of Phagocytic Stimuli
Zymosa n A (S igma) was opsonized by incubating with fresh se rum (5 mg/ml) from a different normal donor for 15 min at 37"C, vort.exin g for 5 min , ce ntrifuging, and restorin g the original concentration in PiCM. PMA (Consolidated Midland Corp., Brewster, New York) was dissolved in dimethyl sulfoxide a nd used at a final co ncentration of 0.2 11g/ ml.
S u.peroxide Anion Production
Washed PMNL (1 X 10 6 ) in 0.8 ml PiCM were preincubatetl wit h se rum (final concentration 10%) for 15 min at 37"C in sterile plastic test tubes. Cytochrome C, horse hea rt, type III solut ion (Sigma Chemical Co., St. Louis, Missouri) , 0.9 mg in 0.1 ml PiCM was added to all tubes just prior to stimulation. Ten microli ters of superoxide dismu tase solution (Miles Biochemicals, Elkhart, Indiana), 1 mg/ml, was added to one tube in eac h triplicate to se rve as control for nonspecific reduction of' cytochrome C. The stimu lus solut ion or PiCM (0.1 ml) was added at zero time to obtain a final volume of 1.0 ml in the stimulated and unstimulated reactio n mixtures. After an additional 15 min at 37"C, the ce ll suspensions were centrifuged at 4"C. Reduced cytochrome C in the co ld cell -free supernates was measured at 550 nm on a spectrophotometer (Model DU-7, Beckman Instruments, Novi, Michigan) and quanti tated using t he extinction coefficient 21.1 mM -'cm-• (reduced-oxidized). 0 2 -generation is expressed as nmol cytochrome C reduced per 1 x 10 6 PMNL per 15 min .
Lysozyme Release
Was hed PMNL (3 X 10") in 0.9 ml PiCM were preincubated with se rum (final concentration, 10%) for 15 min at 37"C followed by add ition of 0.1 ml stimulus so lu t ion or buffe r. After an additional 15 min, t he cell suspensions we re ce ntri tuged and aliquots of the medium were assayed for lysozyme [6) and lactic dehydrogenase (LDH) activities. Cell viabili ty was assessed by measurin g leakage of the cytosolic enzyme LDH . Resu lts are expressed as the percentage of total cellular enzyme released into t he medium by Triton X-100 (0.2 % v/v) .
Phagocytosis
The rate of phagocytosis by PMNL of opso nized, lipopolysacc haridecoated paraffin oil drop lets co ntain ing oil-red-O was measured according to t he method described by Stossel [7] . Results are expressed as milligrams of oi l-red-O ingested per min per 1 X 10 7 PMNL.
Statistics
If not mentioned otherwise, mean values and standard deviations are show n. Data were ana lyzed by Stude nt's t-test (two-tailed) where statistical significnce was defined by a p value of less than 0.05.
RESULTS
Superoxide Anion Generation
Psoriatic PMNL + 10% autologous serum ge nerated significantly less 0 "-compared to normal PMNL + 10% autologous serum (p < .001) when eit her PMA or Z was used as stimulus (Fig 1) . Psoriatic or normal cells incubated with heterologous serum produced comparable intermediate levels of 0~ -. Normal PMNL + heterologous psoriatic serum produced significantly less o~-t ha n normal PMNL + a utologous serum (p < .001) , a nd o~-production was significa ntly increased for psoriat ic PMNL + heterologous normal serum compared to psoriatic PMNL + autologous serum (p < .001) . While variability is seen in t he resul ts of 0 2-ge neration among indivdiuals (Fig 2) , it should be noted t hat in every experiment (n = 17) the same t rend was found: norma l PMNL + normal serum > normal PMNL + psoriatic serum :::= psoriatic PMNL + normal serum >psoriatic PMNL +psoriatic serum. There were no differences in baseline 0 2 -generation in any of t he four mixtures (Fig 1) . Decreased o~-generation by psoriatic PMNL incubated with autologous serum compared to normal serum showed no correlation with t he estimated extent of disease (Table 1) .
To evaluate whether t he results are due to effects of the disease on serum or cells or both, a group of normal a nd psoriatic subjects' neutrophils were studied± autologous serum ± stimulus (Fig 3) . There were no signficant differences in 0 "-ge neration between normal and psoriatic PMNL without serum . When a utologous serum is added, both types of cells demonst rate enhanced o2-generation; however, that of normal cells + serum is significa nt ly increased compared to psoriatic PMNL + serum when either PMA or Z serves as stimulus.
To determine whether the effect of serum on 0 2 -generation is t ime-dependent , we incubated normal and psoriatic PMNL with heterologous serum for variable time interva ls from 0-60
. . min. In 8 experiments, no consistent effect of prolonged preincubation t ime was found (data not shown).
Lyso2yme Release
Results paralleled t hose for 0 1 -generation (Fig 4) . Normal PMNL + autologous serum released significantly more lysozyme t han psoriatic PMNL + auto logous serum with either stimulus, p < .001. Differences between cells + autologous serum a nd cells + heterologous serum did not attain statistical significance. However, t he same trend was obtained in each experiment (n = 7): normal PMNL + autologous serum > normal PMNL + psoriatic serum > psoriatic PMNL + normal serum >psoriatic serum + autologous serum. LDH release was less than 5 % of total cell ular enzyme in each experiment.
CAMISA, KRAUT, AND JAYANTHI-ZVARA
Phagocytosis
The rate of ingestion of oil-red-O by normal PMNL (n = 14) was not different when compared to psoriatic PMNL (n = 8), .094 vs .098 mg/min/10 7 PMNL (Fig 5) . DISCUSSION Previous investigations of PMNL function in psoriatic patients and the effects of their serum on function have had variable results. These differences appear to reflect study technique, patient population, and whether or not PMNL were preincubated with serum. Thus, PMNL of psoriatic patients have been reported to have increased [8] or normal [2, 9] chemotaxis to endotoxin-activated serum, and these results did not correlate with activity of the disease.
Evaluation of the oxygen metabolism of PMNL from psoriatics has also produced divergent results. Using chemiluminescence as a measure of t he ge neration of the reactive oxygen 
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species, hydrogen peroxide, superoxide anion, hydroxyl radical , and singlet oxygen, Schopf et al [10] found enhanced generation of these products by both PMNL and monocytes of psoriat ic patients. On the other hand, Camisa et al [11] found no difference in superoxide generation between psoriatics and normal controls as measured by superoxide dismutase inhibitable cytochrome C reduction . Resting nitroblue tetrazolium (NBT) reduction was normal for psoriatic PMNL, but 48-h cultures of peripheral blood mononuclear cells gave enhanced spontaneous NBT reduction [1 2] . When 10% normal plasma was added to these cultures NBT reduction was decreased by 50 %, but addition of psoriatic plasma had no effect [12] .
Sedgwick et al [1 3,14] also studied the effects of psoriatic serum on o~-generation by normal PMNL. They found increased and decreased o"-generation by normal cells stimulted by Z and PMA, respectively. The apparent difference in our results with zymosan can be explained by different methods of opsonizing zymosan.
In the present study, we attempted to reconcile the differences in reported results by studying several different PMNL functions in the presence and absence of serum using two different stimuli. We found that lyzozyme release and superoxide generation were the same for psoriatic and normal PMNL in the absence of serum. An assay for PMNL phagocytosis that exp loits activation of the alternative complement pathway in autologous serum gave comparable results for psoriatics and controls. However, in the presence of 10% autologous serum, lysozyme release and o"-generation were significantly decreased when psoriatic PMNL were compared to normals.
These data support the hypothesis that serum factor(s) exists in patients with psoriasis that may affect neutrophil functions. These factors may also play a role in the evolution and maintenance of the clinical manifestations of psoriasis. Further support for this concept derives from the recent demonstration that peritoneal dialysis can alter the course of refractory psoriasis [15] . If these hypothetical factors are not present in all psoriatic patients, the differences among the various studies of PMNL function may be explained on this basis.
Recent interest has focused on the role of arachidonic acid metabolites of the 5-and 12-lipoxygenase pathways, monohydroxyeicosatetraenoic acids (HETEs), in the pathogenesis of psoriasis [16] . These highly chemotactic lipids have been found in scales [17] , and soluble 5-lipoxygenase activity has been localized to the psoriatic epidermis [18] . Benoxaprofen, a potent inhibitor of 5-lipoxygenase, improved 75% of patients in a double-blind trial [19] . The effects of purified HETEs on PMNL function have not yet been completely defi ned, but they did slightly inhibit baseline superoxide generation [20] and phagocytosis-associated chemiluminescence [21] at chemotactic concentrations. Whether elevated levels of HETEs in psoriatic serum could explain our observations is currently under investigation .
